Concepedia

Andrew Dmytrijuk

AD

Statistics

Publications

3

Citations

203

H-Index

3

Active since

2008

Affiliations

United States Food and Drug Administration(Current)

Center for Drug Evaluation and Research

Andrew Dmytrijuk is an author at United States Food and Drug Administration.

Publications per year

2008–2018

3

Publications

3

FDA Report: Eculizumab (Soliris®) for the Treatment of Patients with Paroxysmal Nocturnal Hemoglobinuria

Andrew Dmytrijuk, Kathy Robie‐Suh, Martin H. Cohen et al. · The Oncologist · 2008 · 134 citations · Full text

FDA Approval Summary: Lenalidomide as Maintenance Therapy After Autologous Stem Cell Transplant in Newly Diagnosed Multiple Myeloma

Elizabeth Pulte, Andrew Dmytrijuk, Lei Nie et al. · The Oncologist · 2018 · 48 citations · Full text

Eltrombopag for the treatment of chronic immune (idiopathic) thrombocytopenic purpura.

Andrew Dmytrijuk, Kathy Robie‐Suh, Dwaine Rieves et al. · PubMed · 2009 · 21 citations

Rows per page

1–3 of 3